Log inSign up
user avatar
VBL
@VBLTherapeutic
VBL Therapeutics (Nasdaq: VBLT) is developing targeted therapies for immune-inflammatory diseases. VB-601 is expected to enter Phase 1 this year.
Modi'in, Israel
vblrx.com
Joined December 2016
398
Following
222
Followers

@VBLTherapeutic hasn’t posted

When they do, their posts will show up here.